InvestorsHub Logo

CT

01/07/19 4:06 PM

#223068 RE: DewDiligence #223067

Thanks Dew. Wow, 63 study sites recruiting. Trial started 4/2018. Difficulty averaging 2 per site?

Why do you think they opted not to do the biopsy, when other NASH hopefuls are?

DewDiligence

07/14/19 6:32 PM

#225561 RE: DewDiligence #223067

Re: ENTA phase-2a in NASH

The clinicaltrials.gov listing (https://www.clinicaltrials.gov/ct2/show/NCT03421431 ) now says “Primary Completion” Jun 2019 and “Study Completion” Jul 2019. So investors should get the top-line data pretty soon.

DewDiligence

08/06/19 4:14 PM

#225827 RE: DewDiligence #223067

ENTA's phase-2a NASH data for EDP-305 are due in September, according to today's PR.